Skip to main content

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The G-BA Innovation Committee recommends transfer to standard care for another project in Germany

On January 19, 2024, the Innovation Committee at the Federal Joint Committee (G-BA) published the decision recommending the transfer to standard care for another completed project. The project evaluated the web-based initial assessment tool SmED in outpatient emergency care.

The project “DEMAND – Implementation of a standardized initial assessment as the basis for demand management in outpatient emergency care” tested a standardized initial assessment procedure for contact points with emergency service for outpatient care, mainly using the web-based tool SmED (Structured Medical Initial Assessment in Germany). The specialist staff in these contact points were supported in allocating those seeking help to the emergency services, outpatient treatment, or telephone medical advice as needed. The analysis of health insurance data has demonstrated that when the structured initial assessment was used, fewer insured people visited inpatient emergency rooms and could receive outpatient care. The process evaluation also demonstrated that the approach tested in the DEMAND project was not applicable to all patients and that SmED assessed the urgency of medical treatment as being higher overall than the users.

The Innovation Committee will, therefore, forward the obtained results to various stakeholders for consideration.

The full details in German can be found here and here (decision and the results of the DEMAND project).

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.